The mechanism of memory impairment induced by Aβ chronic administration involves imbalance between cytokines and neurotrophins in the rat hippocampus

Current Alzheimer Research

Volumn 8, Issue 4, 2011, Pages 410-420

  Ji, C ^a,b   Song, C ^a,b   Zuo, P ^a,b  

^a UNIVERSITY OF PRINCE EDWARD ISLAND   (Canada)

^b INSTITUTE OF BASIC MEDICAL SCIENCES   (China)

Author keywords

(A ); Alzheimer's disease (AD); Amyloid ; Astrocytes; Inflammatory cytokines; Microglia; Neurotrophic factors (NTFs)

Indexed keywords

AMYLOID BETA PROTEIN[25-35]; BRAIN DERIVED NEUROTROPHIC FACTOR; CELL PROTEIN; GLIAL CELL LINE DERIVED NEUROTROPHIC FACTOR; GLIAL FIBRILLARY ACIDIC PROTEIN; IBA1 PROTEIN; INTERLEUKIN 1ALPHA; INTERLEUKIN 1BETA; NERVE GROWTH FACTOR; TUMOR NECROSIS FACTOR; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL ACTIVATION; CELL SURVIVAL; CONTROLLED STUDY; DENTATE GYRUS; GENE EXPRESSION; GENETIC TRANSCRIPTION; GLIA CELL; HIPPOCAMPAL CA2 REGION; HIPPOCAMPAL CA3 REGION; HIPPOCAMPUS; LEARNING; MALE; MEMORY DISORDER; MOLECULAR INTERACTION; NERVE CELL NECROSIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT;

AMYLOID BETA-PEPTIDES; ANIMALS; CYTOKINES; DISEASE MODELS, ANIMAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; GLIAL FIBRILLARY ACIDIC PROTEIN; HIPPOCAMPUS; INJECTIONS, INTRAVENTRICULAR; MALE; MAZE LEARNING; MEMORY DISORDERS; NERVE GROWTH FACTORS; PEPTIDE FRAGMENTS; RATS; RATS, LONG-EVANS;

EID: 79959364794     PISSN: 15672050     EISSN: 18755828     Source Type: Journal    
DOI: 10.2174/156720511795745366     Document Type: Article

References (37)

1. Selkoe DJ. The molecular pathology of Alzheimer's disease. Neuron 6: 487-98 (1991).
2. Walsh DM, Selkoe DJ. Deciphering the molecular basis of memory failure in Alzheimer's disease. Neuron 44: 181-193 (2004).
3. Hardy J, Selkoe DJ. The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics. Science 297: 353-356 (2002).
4. Miao J, Zhang W, Yin R, Liu R, Su C, Lei G, et al. S14G-Humanin ameliorates Abeta25-35-induced behavioral deficits by reducing neuroinflammatory responses and apoptosis in mice. Neuropeptides 42: 557-567 (2008).
5. Parachikova A, Nichol KE, Cotman CW. Short-term exercise in aged Tg2576 mice alters neuroinflammation and improves cognition. Neurobiol Dis 30: 121-129 (2008).
6. Beckman JS, Crow JP. Pathological implications of nitric oxide, superoxide and peroxynitrite formation. Biochem Soc Trans 21: 330-334 (1993).
7. Benveniste EN, Nguyen VT, O'Keefe GM. Immunological aspects of microglia: relevance to Alzheimer's disease. Neurochem Int 39: 381-391 (2001).
8. Coraci IS, Husemann J, Berman JW, Hulette C, Dufour JH, Campanella GK, et al. CD36, a class B scavenger receptor, is expressed on microglia in Alzheimer's disease brains and can mediate production of reactive oxygen species in response to beta-amyloid fibrils. Am J Pathol 160: 101-112 (2002).
9. Mattson MP, Pedersen WA, Duan W, Culmsee C, Camandola S. Cellular and molecular mechanisms underlying perturbed energy metabolism and neuronal degeneration in Alzheimer's and Parkinson's diseases. Ann N Y Acad Sci 893: 154-175 (1999).
10. Teismann P, Schulz JB. Cellular pathology of Parkinson's disease: astrocytes, microglia and inflammation. Cell Tissue Res 318: 149-161 (2004).
11. Nakajima K, Honda S, Tohyama Y, Imai Y, Kohsaka S, Kurihara T. Neurotrophin secretion from cultured microglia. J Neurosci Res 65: 322-331 (2001).
12. Blasko I, Stampfer-Kountchev M, Robatscher P, Veerhuis R, Eikelenboom P, Grubeck-Loebenstein B. How chronic inflammation can affect the brain and support the development of Alzheimer's disease in old age: the role of microglia and astrocytes. Aging Cell 3: 169-176 (2004).
13. Connor B, Dragunow M. The role of neuronal growth factors in neurodegenerative disorders of the human brain. Brain Res Brain Res Rev 27: 1-39 (1998).
14. Cotman CW. The role of neurotrophins in brain aging: a perspective in honor of Regino Perez-Polo. Neurochem Res 30: 877-881 (2005).
15. Spedding M, Gressens P. Neurotrophins and cytokines in neuronal plasticity. Novartis Found Symp 289: 222-233; discussion 33-40 (2008).
16. Takei Y, Laskey R. Interpreting crosstalk between TNF-alpha and NGF: potential implications for disease. Trends Mol Med 14: 381-388 (2008).
17. Kuno R, Yoshida Y, Nitta A, Nabeshima T, Wang J, Sonobe Y, et al. The role of TNF-alpha and its receptors in the production of NGF and GDNF by astrocytes. Brain Res 1116: 12-18 (2006).
18. Takei Y, Laskey R. Tumor necrosis factor alpha regulates responses to nerve growth factor, promoting neural cell survival but suppressing differentiation of neuroblastoma cells. Mol Biol Cell 19: 855-864 (2008).
19. Barker V, Middleton G, Davey F, Davies AM. TNFalpha contributes to the death of NGF-dependent neurons during development. Nat Neurosci 4: 1194-1198 (2001).
20. DeLegge MH, Smoke A. Neurodegeneration and inflammation. Nutr Clin Pract 23: 35-41 (2008).
21. Rojo LE, Fernandez JA, Maccioni AA, Jimenez JM, Maccioni RB. Neuroinflammation: implications for the pathogenesis and molecular diagnosis of Alzheimer's disease. Arch Med Res 39: 1-16 (2008).
22. Heese K, Hock C, Otten U. Inflammatory signals induce neurotro-phin expression in human microglial cells. J Neurochem 70: 699-707 (1998).
23. Copray S, Kust B, Emmer B, Lin MY, Liem R, Amor S, et al. Deficient p75 low-affinity neurotrophin receptor expression exacerbates experimental allergic encephalomyelitis in C57/BL6 mice. J Neuroimmunol 148: 41-53 (2004).
24. Monji A, Utsumi H, Ueda T, Imoto T, Yoshida I, Hashioka S, et al. Amyloid-beta-protein (A beta) (25-35)-associated free radical generation is strongly influenced by the aggregational state of the pep-tides. Life Sci 70: 833-841 (2002).
25. Maurice T, Lockhart BP, Privat A. Amnesia induced in mice by centrally administered beta-amyloid peptides involves cholinergic dysfunction. Brain Res 706: 181-193 (1996).
26. Delobette S, Privat A, Maurice T. In vitro aggregation facilities beta-amyloid peptide-(25-35)-induced amnesia in the rat. Eur J Pharmacol 319: 1-4 (1997).
27. Song C, Phillips AG, Leonard BE, Horrobin DF. Ethyl-eicosapentaenoic acid ingestion prevents corticosterone-mediated memory impairment induced by central administration of interleu-kin-1beta in rats. Mol Psychiatry 9: 630-638 (2004).
28. Clarke J, Thornell A, Corbett D, Soininen H, Hiltunen M, Jolkkonen J. Overexpression of APP provides neuroprotection in the absence of functional benefit following middle cerebral artery occlusion in rats. Eur J Neurosci 26: 1845-1852 (2007).
29. Maeda T, Nagata K, Yoshida Y. Exogenous l-DOPA induce no dopamine immuno-reactivity in striatal astroglias and microglias of adult rats with extensive nigro-striatal dopaminergic denervation. Neurosci Lett 433: 255-258 (2008).
30. Itoh A, Nitta A, Nadai M, Nishimura K, Hirose M, Hasegawa T, et al. Dysfunction of cholinergic and dopaminergic neuronal systems in beta-amyloid protein--infused rats. J Neurochem 66: 1113-1117 (1996).
31. Burgos-Ramos E, Hervas-Aguilar A, Puebla-Jimenez L, Boyano-Adanez MC, Arilla-Ferreiro E. Chronic but not acute intracere-broventricular administration of amyloid beta-peptide(25-35) decreases somatostatin content, adenylate cyclase activity, soma-tostatin-induced inhibition of adenylate cyclase activity, and adeny-late cyclase I levels in the rat hippocampus. J Neurosci Res 85: 433-442 (2007).
32. Nag S, Yee BK, Tang F. Reduction in somatostatin and substance P levels and choline acetyltransferase activity in the cortex and hippocampus of the rat after chronic intracerebroventricular infusion of beta-amyloid (1-40). Brain Res Bull 50: 251-262 (1999).
33. Yamaguchi Y, Kawashima S. Effects of amyloid-beta-(25-35) on passive avoidance, radial-arm maze learning and choline acetyl-transferase activity in the rat. Eur J Pharmacol 412: 265-272 (2001).
34. Sun MK, Alkon DL. Impairment of hippocampal CA1 heterosyn-aptic transformation and spatial memory by beta-amyloid(25-35). J Neurophysiol 87: 2441-2449 (2002).
35. Bierer LM, Haroutunian V, Gabriel S, Knott PJ, Carlin LS, Purohit DP, et al. Neurochemical correlates of dementia severity in Alzheimer's disease: relative importance of the cholinergic deficits. J Neurochem 64: 749-760 (1995).
36. Sofroniew MV, Howe CL, Mobley WC. Nerve growth factor signaling, neuroprotection, and neural repair. Annu Rev Neurosci 24: 1217-1281 (2001).
37. Koistinaho M, Lin S, Wu X, Esterman M, Koger D, Hanson J, et al. Apolipoprotein E promotes astrocyte colocalization and degradation of deposited amyloid-beta peptides. Nat Med 10: 719-726 (2004).